HUP0002324A2 - Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0002324A2 HUP0002324A2 HU0002324A HUP0002324A HUP0002324A2 HU P0002324 A2 HUP0002324 A2 HU P0002324A2 HU 0002324 A HU0002324 A HU 0002324A HU P0002324 A HUP0002324 A HU P0002324A HU P0002324 A2 HUP0002324 A2 HU P0002324A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- aralkyl
- alkenyl
- alkoxy
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 125000005024 alkenyl aryl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004858 cycloalkoxyalkyl group Chemical group 0.000 abstract 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
A találmány szerinti új vegyületek (n) általánosképletében R1 jelentése hidrogénatom, alkilcsoport, alkoxicsoport vagyalkil-tio-csoport, R2 jelentése aralkil- vagy heteroaralkil csoport,amely adott esetben, egy vagy több halogénatom, alkilcsoport, halogén-alkil-csoport, nitrocsoport, alkoxi-karbonil-csoport, aromás csoport,aralkil-oxi-csoport, cikloalkil-oxi-alkil-csoport, aralkilcsoport,aralkenilcsoport, aralkinilcsoport, aromás-oxi-alkilcsoport,cikloalkil-alkil-oxi-csoport, alkenilcsoport, alkoxi-csoport, alkil-tio-csoport, alkán-szulfinil-csoport, alkán-szulfonil-csoport ésalkán-szulfonil-karbamoil-csoport közül megválasztott szubsztituensselszubsztituálva lehet, R3 jelentése alkilcsoport, hidroxi-alkil-csoport, alkenilcsoport, aromás csoport, halogénezett aromás csoport,alkil-aril-csoport, alkenil-aril-csoport, aralkilcsoport vagyaralkenilcsoport, -X- jelentése (II)-(VI) képletű csoport. A találmánykiterjed a fenti vegyületeket tartalmazó gyógyszerkészítményekre,amelyek a vér cukorszintjét csökkentő vagy PDE5 inhibitor hatássalrendelkeznek. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18769697 | 1997-06-27 | ||
JP7635798 | 1998-03-25 | ||
PCT/JP1998/002885 WO1999000373A1 (fr) | 1997-06-27 | 1998-06-26 | Derives de benzimidazole |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0002324A2 true HUP0002324A2 (hu) | 2001-05-28 |
HUP0002324A3 HUP0002324A3 (en) | 2001-07-30 |
Family
ID=26417500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0002324A HUP0002324A3 (en) | 1997-06-27 | 1998-06-26 | Benzimidazole derivatives and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
US (1) | US6420409B1 (hu) |
EP (1) | EP1020452A4 (hu) |
KR (1) | KR20010014166A (hu) |
CN (1) | CN1135224C (hu) |
AR (1) | AR016108A1 (hu) |
AU (1) | AU748541B2 (hu) |
BR (1) | BR9811273A (hu) |
CA (1) | CA2294505A1 (hu) |
HK (1) | HK1028246A1 (hu) |
HU (1) | HUP0002324A3 (hu) |
IL (1) | IL133674A0 (hu) |
RU (1) | RU2243968C2 (hu) |
TR (1) | TR199903277T2 (hu) |
TW (1) | TW453999B (hu) |
WO (1) | WO1999000373A1 (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2295239A1 (en) * | 1997-06-27 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Sulfonamide compounds and medicinal use thereof |
WO1999051574A1 (fr) * | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Derives d'indole |
WO2000028991A1 (fr) * | 1998-11-13 | 2000-05-25 | Fujisawa Pharmaceutical Co., Ltd. | Remedes contre le syndrome des ovaires polykystiques |
WO2000039099A1 (fr) * | 1998-12-24 | 2000-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Derives de benzimidazole |
US6432989B1 (en) | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
US6525067B1 (en) | 1999-11-23 | 2003-02-25 | Pfizer Inc | Substituted heterocyclic derivatives |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
EP1442042A1 (en) | 2001-11-09 | 2004-08-04 | Schering Corporation | Polycyclic guanine derivative phosphodiesterase v inhibitors |
US20050032854A1 (en) * | 2001-12-03 | 2005-02-10 | Kiminori Kawahara | Insulin resistance improving agents |
US20030181461A1 (en) * | 2002-01-25 | 2003-09-25 | Lautt Wilfred Wayne | Use of phosphodiesterase antagonists to treat insulin resistance |
AU2003223093B2 (en) * | 2002-05-03 | 2010-02-04 | Israel Institute For Biological Research | Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
AU2003902860A0 (en) * | 2003-06-06 | 2003-06-26 | Daicel Chemical Industries, Ltd | Benzimidazole compounds |
US20050197376A1 (en) * | 2004-03-02 | 2005-09-08 | Fujisawa Pharmaceutical Co. Ltd. | Concomitant drugs |
EP1983992A4 (en) * | 2006-01-19 | 2010-08-18 | Abbott Lab | 2-IMINO-BENZIMIDAZOLES |
WO2011063339A1 (en) * | 2009-11-23 | 2011-05-26 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl donors for the treatment of pulmonary hypertension |
CN105919987B (zh) * | 2009-12-07 | 2020-04-03 | 约翰斯霍普金斯大学 | N-酰氧基磺酰胺和n-羟基-n-酰基磺酰胺衍生物及其用途 |
CA2782248A1 (en) | 2009-12-07 | 2011-06-16 | Cardioxyl Pharmaceuticals, Inc. | Bis-acylated hydroxylamine derivatives |
JP5990106B2 (ja) * | 2011-01-28 | 2016-09-07 | 佐藤製薬株式会社 | 縮環化合物 |
JP6456520B2 (ja) | 2015-12-11 | 2019-01-23 | 帝人ファーマ株式会社 | アミノアゾール誘導体 |
WO2017192728A1 (en) | 2016-05-03 | 2017-11-09 | Virginia Commonwealth University | Heteroatom -doped porous carbons for clean energy applications and methods for their synthesis |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE676196C (de) | 1936-08-21 | 1939-05-30 | I G Farbenindustrie Akt Ges | Verfahren zur Herstellung von Imidazolverbindungen |
US3152142A (en) | 1962-05-24 | 1964-10-06 | Dow Chemical Co | Benzimidazole compounds |
FR2291749A1 (fr) | 1974-11-20 | 1976-06-18 | Delalande Sa | Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique |
JPS51133267A (en) | 1975-05-08 | 1976-11-18 | Lilly Co Eli | Substituted 11sulphonyl benzimidazole |
US4179505A (en) | 1977-03-30 | 1979-12-18 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
US4243806A (en) | 1979-06-13 | 1981-01-06 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
GB2053215B (en) | 1979-06-25 | 1983-04-07 | May & Baker Ltd | Benzimidazole derivatives |
JPS625966A (ja) | 1985-07-03 | 1987-01-12 | Nippon Shinyaku Co Ltd | ベンズイミダゾ−ル誘導体 |
NZ221729A (en) | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
CA2004911A1 (en) | 1988-12-22 | 1990-06-22 | Mitsuaki Ohta | 4,5,6,7-tetrahydrobenzimidazole derivatives |
DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
WO1991016313A1 (en) | 1990-04-13 | 1991-10-31 | Smithkline Beecham Corporation | Substituted benzimidazoles |
US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
US5703110A (en) | 1990-04-27 | 1997-12-30 | Takeda Chemical Industries, Ltd. | Benzimidazole derivatives, their production and use |
RU1836357C (ru) | 1990-07-23 | 1993-08-23 | Др.Карл Томэ ГмбХ | Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами |
DE4023369A1 (de) * | 1990-07-23 | 1992-01-30 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5602127A (en) | 1991-02-06 | 1997-02-11 | Karl Thomae Gmbh | (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists |
SI9210098B (sl) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
US5594003A (en) | 1991-02-06 | 1997-01-14 | Dr. Karl Thomae Gmbh | Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists |
DE4224133A1 (de) * | 1992-07-22 | 1994-01-27 | Thomae Gmbh Dr K | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5591762A (en) | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
US5407835A (en) | 1991-07-31 | 1995-04-18 | Abbott Laboratories | Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
GB9121776D0 (en) | 1991-10-14 | 1991-11-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives and process for preparation thereof |
DE4237557A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituierte Benzimidazole |
JPH0853424A (ja) | 1994-08-11 | 1996-02-27 | Kureha Chem Ind Co Ltd | ベンズイミダゾールスルホン酸アミド誘導体 |
GB9423910D0 (en) | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
EP0882718B1 (en) * | 1995-12-28 | 2005-08-31 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
-
1998
- 1998-06-25 TW TW087110304A patent/TW453999B/zh not_active IP Right Cessation
- 1998-06-26 AR ARP980103128A patent/AR016108A1/es unknown
- 1998-06-26 KR KR1019997012237A patent/KR20010014166A/ko not_active Application Discontinuation
- 1998-06-26 AU AU79346/98A patent/AU748541B2/en not_active Ceased
- 1998-06-26 WO PCT/JP1998/002885 patent/WO1999000373A1/ja not_active Application Discontinuation
- 1998-06-26 CA CA002294505A patent/CA2294505A1/en not_active Abandoned
- 1998-06-26 HU HU0002324A patent/HUP0002324A3/hu unknown
- 1998-06-26 IL IL13367498A patent/IL133674A0/xx unknown
- 1998-06-26 RU RU2000101811/04A patent/RU2243968C2/ru not_active IP Right Cessation
- 1998-06-26 CN CNB988085798A patent/CN1135224C/zh not_active Expired - Fee Related
- 1998-06-26 US US09/446,749 patent/US6420409B1/en not_active Expired - Fee Related
- 1998-06-26 BR BR9811273-2A patent/BR9811273A/pt not_active IP Right Cessation
- 1998-06-26 EP EP98929723A patent/EP1020452A4/en not_active Withdrawn
- 1998-06-26 TR TR1999/03277T patent/TR199903277T2/xx unknown
-
2000
- 2000-11-22 HK HK00107463A patent/HK1028246A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1135224C (zh) | 2004-01-21 |
HUP0002324A3 (en) | 2001-07-30 |
AU7934698A (en) | 1999-01-19 |
RU2243968C2 (ru) | 2005-01-10 |
CA2294505A1 (en) | 1999-01-07 |
HK1028246A1 (en) | 2001-02-09 |
EP1020452A4 (en) | 2003-04-02 |
WO1999000373A1 (fr) | 1999-01-07 |
TW453999B (en) | 2001-09-11 |
US6420409B1 (en) | 2002-07-16 |
WO1999000373A8 (fr) | 2000-07-20 |
AU748541B2 (en) | 2002-06-06 |
AR016108A1 (es) | 2001-06-20 |
BR9811273A (pt) | 2000-07-18 |
CN1268123A (zh) | 2000-09-27 |
KR20010014166A (ko) | 2001-02-26 |
IL133674A0 (en) | 2001-04-30 |
TR199903277T2 (xx) | 2000-07-21 |
EP1020452A1 (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0002324A2 (hu) | Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
FI935529A (fi) | Aminometylensubstituerade icke-aromatiska heterocykliska foereningar | |
HUP0002483A2 (hu) | CETP aktivítást gátló vegyületek | |
NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
DK459086D0 (da) | Quinazolinderivater | |
NO953305D0 (no) | Antranilsyrederivat | |
DK1023308T3 (da) | Inhibitorer af nukleosidmetabolisme | |
HUP0103413A2 (hu) | Heterociklusos származékok mint rotamáz-enzimek inhibitorai, köztitermékei, eljárás ezek előállítására, és ezeket tartalmazó gyógyszerkészítmények | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
HUP0402235A2 (hu) | 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények | |
HUP0002239A2 (hu) | Tieno-pirimidin-származékok alkalmazása gombák leküzdésére | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
HUP0203487A2 (hu) | Tetrahidrotiopirán-ftalazinon-származékok, mint PDE4-inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
NZ228065A (en) | 1,2,4-triazinediones and parasiticidal compositions; processes for preparation | |
ES2001106A6 (es) | Procedimiento para la obtencion de 1-aril-pirazoles | |
HUP0203478A2 (hu) | Új tiazolidin-dion-származékok, mint antidiabéteszes szerek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
IL115084A (en) | Carbamoylcarboxamides fungicidal compositions containing them and their preparation | |
ATE191465T1 (de) | Carbamoylcarbonsäureamide | |
BR0211180A (pt) | Compostos, processo para preparar os mesmos, intermediários, e, composição adequada e método para controlar fungos fitopatogênicos | |
DE69228877D1 (de) | Benzoaxole,benzothiazol und benzimidazol derivate als fungizide | |
ATE106891T1 (de) | 2'-deoxy-5-fluorouridin-derivate. | |
DK562783A (da) | Pyrrolidinderivater og deres fremstilling samt laegemidler indeholdende saadanne derivater | |
EE9900238A (et) | Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon | |
NO985298D0 (no) | Polyhydroksyfenolderivater og preventive og terapeutiske midler for ben- og brusksykdommer inneholdende disse | |
HUP0302263A2 (hu) | Higromicinszármazékok és ezeket tartalmazó gyógyászati készítmények bakteriális és protozoon fertőzések kezelésére |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |